Holmes Biopharma, Inc.
OTC Bulletin Board : HLMB

Holmes Biopharma, Inc.

September 29, 2005 09:00 ET

Holmes Herbs, Inc.: Qualia Completes Research Contract for Ferring Pharmaceuticals

SCOTTSDALE, ARIZONA--(CCNMatthews - Sept. 29, 2005) - Holmes Herbs, Inc., (OTCBB:HMHB), announced today that its clinical research partner, Qualia Clinical Research Services Inc. ("Qualia"), recently completed a clinical research contract on behalf of Ferring Pharmaceuticals.

The clinical research for Ferring Pharmaceuticals involved a Phase 3 trial on a new formulation to treat enuresis (bedwetting). Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of urology, gynecology & obstetrics.

Holmes Herbs, Inc. is acquiring Qualia, a transaction expected to close on or before November 30, 2005.

On behalf of the Board of Directors

John F. Metcalfe, President and CEO

Certain statements in this press release constitute "forward-looking statements" within the meaning of the United States Securities Legislation. The Company's actual results could differ from those in the forward-looking statements. Do not construe this information as investment advice. This is not a solicitation to buy or sell securities. This does not purport to be a complete analysis of the Company. Investing in securities is speculative and carries a high degree of risk. Past performance does not guarantee future results. Readers should consult their own independent advisers with any investment, including any contemplated investment. All information contained in this press release should be independently investigated. This press release contains forward-looking statements. These remarks involve risks and uncertainties. Risks are not limited to quarterly fluctuations in results or the companies' management of growth and competition. Other risks are detailed in the Company's SEC filings. Actual results may differ materially from such information set forth herein.

Contact Information